Galapagos increases share capital through subscription right exercises
Mechelen, Belgium; 19 March 2021, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from subscription right exercises.
Galapagos issued 99,814 new ordinary shares on 19 March 2021, for a total capital increase (including issuance premium) of €2,258,042.82.
Pursuant to the subscription right exercise program of Galapagos’ management board, members of the management board automatically are committed to exercise a minimum number of subscription rights, subject to certain conditions. In accordance with the rules of this program, CEO Onno van de Stolpe exercised 15,000 subscription rights and in total he exercised 41,874 subscription rights. These 41,874 subscription rights were due to expire in May 2021 and this exercise window was his last possibility to exercise. Two other management board members exercised an aggregate number of 10,000 subscription rights.
In accordance with Belgian transparency legislation1, Galapagos notes that its total share capital currently amounts to €354,359,437.71, the total number of securities conferring voting rights amounts to 65,511,581, which is also the total number of voting rights (the “denominator”), and all securities conferring voting rights and all voting rights are of the same category. The total number of rights (formerly known as warrants) to subscribe to not yet issued securities conferring voting rights is (i) 6,792,843 subscription rights under several outstanding employee subscription right plans, which equals 6,792,843 voting rights that may result from the exercise of those subscription rights, and (ii) one subscription right issued to Gilead Therapeutics to subscribe for a maximum number of shares that is sufficient to bring the shareholding of Gilead and its affiliates to 29.9% of the actually issued and outstanding shares after the exercise of the subscription right. Galapagos does not have any convertible bonds or shares without voting rights outstanding.
Galapagos (Euronext & NASDAQ: GLPG) discovers and develops small molecule medicines with novel modes of action, several of which show promising patient results and are currently in late-stage development in multiple diseases. Our pipeline comprises Phase 3 through to discovery programs in inflammation, fibrosis, and other indications. Our ambition is to become a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines. More information at www.glpg.com.
VP Investor Relations
+1 781 460 1784
Sofie Van Gijsel
Senior Director Investor Relations
+32 485 19 14 15
Global Head of Communications & Public Affairs
+32 473 824 874
Senior Director Therapy Areas Communications
+44 7717 801900
This release may contain forward-looking statements. Such forward-looking statements are not guarantees of future results. These forward-looking statements speak only as of the date of publication of this document. Galapagos expressly disclaims any obligation to update any forward-looking statements in this document, unless specifically required by law or regulation.
1 Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers whose shares are admitted to trading on a regulated market
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States19.4.2021 07:02:32 CEST | Press release
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States Mont-Saint-Guibert, Belgium – 19 April 2021 – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has confidentially submitted a draft Registration Statement on Form F-1 to the Securities and Exchange Commission (the "SEC") relating to the proposed public offering of its ordinary shares in the United States. The number of ordinary shares to be offered and the price for the proposed offering have not yet been determined. The public offering is expected to take place after the SEC completes its review process, subject to market and other conditions. This announcement is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as am
Millicom signs agreements to conclude Africa divestiture program19.4.2021 06:05:00 CEST | Press release
Millicomsigns agreements to conclude Africa divestiture program Luxembourg,April19, 2021 – Millicom International Cellular S.A. (“Millicom”) announces that it has signed agreements for the sale of its operations in Tanzania and for its stake in the AirtelTigo joint venture in Ghana. Once closed, the transactions will complete Millicom’s multi-year plan to divest its African operations and focus on its Latin America markets. In Tanzania, Millicom has agreed to sell its entire operations to a consortium led by Axian, a pan-African group that was part of the consortium that acquired Millicom’s operations in Senegal in 2018. In Ghana, Millicom along with its joint venture partner, Bharti Airtel Limited, have signed a definitive agreement for the transfer of AirtelTigo to the Government of Ghana. Millicom will take a $25 million charge as a result of this agreement. Millicom CEO, Mauricio Ramos, commented: “Today Tigo is a leading provider of broadband services to consumers, businesses and
Nokia to deploy indoor 5G small cells solutions with LG Uplus in South Korea19.4.2021 03:00:00 CEST | Press release
Press Release Nokia to deploy indoor 5G small cells solutions with LG Uplus in South Korea Nokia will expand and enhance LG Uplus’ 5G network, enabling seamless 5G connectivity between indoor and outdoor locationsLG Uplus will use Nokia’s AirScale indoor solution which can be deployed flexibly and upgraded easily The deal continues the long-standing partnership between the two companies 19 April 2021 Espoo, Finland – Nokia today announced an agreement with LG Uplus to expand 5G coverage by installing new equipment from Nokia’s comprehensive AirScale portfolio across the country, enabling seamless 5G indoor and outdoor connectivity. The dealis expected to accommodate future network expansion and will further deepen the partnership between the two companies, which have already collaborated on LTE, 5G and digital projects. Being the first deployment of its kind in South Korea, Nokia will install its cost-effective, next-generation small cell AirScale Indoor (ASiR) systems in a range of in
FRO - Notice of Annual General Meeting 202116.4.2021 22:15:00 CEST | Press release
Frontline Ltd. (the “Company”) announces that its 2021 Annual General Meeting will be held on May 26, 2021. A copy of the Notice of Annual General Meeting and associated information including the Company’s Annual Report on Form 20-F for 2020 can be found on our website at www.frontline.bm and attached to this press release. April 16, 2021 The Board of Directors Frontline Ltd. Hamilton, Bermuda This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. Attachments FRO - Notice of Annual General Meeting 2021FRO - 2020 Annual Report on Form 20-F
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV16.4.2021 17:40:00 CEST | Press release
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV Since the quorum required for the Extraordinary General Meeting of Shareholders of 22 April 2021 will not be attained, ageas SA/NV is organising the Ordinary and Extraordinary Meeting of Shareholders (the "Meeting") on Wednesday 19 May 2021 at 10:30 a.m. The Meeting is being held at The Egg, Barastraat 175, 1070 Brussels, and is being organised in accordance with the Corona measures applicable on the day of the Meeting. Shareholders are advised to consult the Ageas website (www.ageas.com) for any additional information on this subject. If the current measures remain unchanged, it will not be permitted to physically attend the Meeting. In that case, registered shareholders who have indicated that they wish to vote online will be able to follow the Meeting via a webcast. They are invited to consult in advance the Ageas website, where the procedure to log in for the webcast will be published. Ag
CONDITIONS FOR THE RIKSBANK´S PURCHASES OF COMMERCIAL PAPER16.4.2021 16:20:00 CEST | Press release
Bid procedure, 2021-04-21CertificateCommercial paper issued in SEK by non-financial companies with their registered office in Sweden and with a remaining maturity of up to six months on the Bid date. i.e. with the latest maturity date as of 2021-10-21 Delivery may not be made in commercial paper purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Special terms, i.e. the purchase may not have been made after 2021-04-09 BidsCounterparties may make one bid per Credit rating class and maturity class. Bids are made to tel 08-696 69 70 and confirmed by e-mail to EOL@riksbank.se.Bid date2021-04-21Bid times09.00-09.30 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SEK 4 billionHighest permitted bid volume (corresponding nominal amount)The total bid volume from one Counterparty for the two Credit rating classes may not exceed SEK 4 billion. No bid may contain Commercial paper in excess of SEK 250 million issued by the s
CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK TREASURY BILLS16.4.2021 16:20:00 CEST | Press release
Bid procedure, 2021-04-21BillsSWEDISH T-BILL: SE0015811351. 2021-07-21 SWEDISH T-BILL: SE0014808747, 2021-09-15 Bid date2021-04-21Bid times10.00-11.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SE0015811351: 1250 mln SEK +/-600 mln SEK SE0014808747: 1000 mln SEK +/-500 mln SEK Highest permitted bid volume (corresponding nominal amount)SE0015811351: 1250 mln SEK per bid SE0014808747: 1000 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 11.15 (CET/CEST) on the Bid dateDelivery and payment date2021-04-23Delivery of billsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2021-04-16 This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms